0:18
In this brief YouTube excerpt, Sam Parr and an unnamed speaker discuss the public backlash against the individual dubbed "the most hated man in America," referring to Martin Shkreli. The conversation highlights Shkreli's decision to raise the price of the antiparasitic drug Daraprim from about $13 to $500 per dose, his unapologetic and boastful reaction to the criticism, and his ownership of two publicly traded pharmaceutical companies each valued at over a billion dollars. The dialogue underscores themes of pharmaceutical pricing ethics, corporate power, and media attention.
